The new major version with a new JIT compiler, a revised parallelization API, and a maturing type system paves the way for ...
Black Book Research Q4 flash survey shows health plans shifting from effort-based sourcing to KPI-backed operating models, ...
YARTEMLEA is approved by the U.S. FDA for the treatment of TA-TMA in adults and in children ages two years and older. A marketing authorization application for YARTEMLEA for TA-TMA is under review by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results